These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2518594)
1. Ribosomal antibody response in rabbits and mice infected with Trypanosoma cruzi. Sosa Miatello C; Fiorotto ER Rev Argent Microbiol; 1989; 21(3-4):141-5. PubMed ID: 2518594 [TBL] [Abstract][Full Text] [Related]
2. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. Braun M; de Titto E Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884 [TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895 [TBL] [Abstract][Full Text] [Related]
4. Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins. Bonfa E; Viana VS; Barreto AC; Yoshinari NH; Cossermelli W J Immunol; 1993 May; 150(9):3917-23. PubMed ID: 8473740 [TBL] [Abstract][Full Text] [Related]
5. The immunology of experimental Chagas' disease. IV. Production of lesions in rabbits similar to those of chronic Chagas' disease in man. Teixeira AR; Teixeira ML; Santos-Buch CA Am J Pathol; 1975 Jul; 80(1):163-80. PubMed ID: 808136 [TBL] [Abstract][Full Text] [Related]
6. In vivo administration of recombinant IFN-gamma induces macrophage activation, and prevents acute disease, immune suppression, and death in experimental Trypanosoma cruzi infections. Reed SG J Immunol; 1988 Jun; 140(12):4342-7. PubMed ID: 3131431 [TBL] [Abstract][Full Text] [Related]
7. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients. Zúñiga E; Montes C; Barbieri G; Gruppi A Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of immune responses raised against Tc13 antigens of Trypanosoma cruzi in the outcome of murine experimental infection. García GA; Arnaiz MR; Esteva MI; Laucella SA; Garavaglia PA; Ibarra SE; Ruiz AM Parasitology; 2008 Mar; 135(3):347-57. PubMed ID: 17991305 [TBL] [Abstract][Full Text] [Related]
9. Antibody response to heat shock proteins and histopathology in mice infected with Trypanosoma cruzi and maintained at elevated temperature. Arif AA; Gao L; Davis CD; Helm DS J Parasitol; 1999 Dec; 85(6):1089-99. PubMed ID: 10647042 [TBL] [Abstract][Full Text] [Related]
10. Identification of novel vaccine candidates for Chagas' disease by immunization with sequential fractions of a trypomastigote cDNA expression library. Tekiel V; Alba-Soto CD; González Cappa SM; Postan M; Sánchez DO Vaccine; 2009 Feb; 27(9):1323-32. PubMed ID: 19162108 [TBL] [Abstract][Full Text] [Related]
12. Trypanosoma cruzi-infected individuals demonstrate varied antibody responses to a panel of trans-sialidase proteins encoded by SA85-1 genes. Duthie MS; Cetron MS; Van Voorhis WC; Kahn SJ Acta Trop; 2005 Mar; 93(3):317-29. PubMed ID: 15725381 [TBL] [Abstract][Full Text] [Related]
13. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp]. Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482 [TBL] [Abstract][Full Text] [Related]
14. [Immune response in Trypanosoma cruzi infection]. Rottenberg ME; de Titto EH; Cardoni RL; Segura EL Rev Argent Microbiol; 1991; 23(2):101-21. PubMed ID: 1815267 [No Abstract] [Full Text] [Related]
15. Identification of antigens of Trypanosoma cruzi which induce antibodies during experimental Chagas' disease. Grögl M; Kuhn RE J Parasitol; 1985 Apr; 71(2):183-91. PubMed ID: 3923183 [TBL] [Abstract][Full Text] [Related]
16. GP 50/55, a membrane antigen of Trypanosoma cruzi involved in autoimmunity and immunosuppression. Hernández-Munaín C; De Diego JL; Bonay P; Gironés N; Fresno M Biol Res; 1993; 26(1-2):209-18. PubMed ID: 7670533 [TBL] [Abstract][Full Text] [Related]
17. Evidence for cross-reactivity between antigen derived from Trypanosoma cruzi and myelin basic protein in experimental Chagas disease. Al-Sabbagh A; Garcia CA; Diaz-Bardales BM; Zaccarias C; Sakurada JK; Santos LM Exp Parasitol; 1998 Jul; 89(3):304-11. PubMed ID: 9676708 [TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi: recognition of a 43-kDa muscle glycoprotein by autoantibodies present during murine infection. McCormick TS; Rowland EC Exp Parasitol; 1993 Nov; 77(3):273-81. PubMed ID: 8224083 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi acidic ribosomal P protein gene family. Novel P proteins encoding unusual cross-reactive epitopes. Skeiky YA; Benson DR; Guderian JA; Sleath PR; Parsons M; Reed SG J Immunol; 1993 Nov; 151(10):5504-15. PubMed ID: 7693813 [TBL] [Abstract][Full Text] [Related]
20. Experimental chemotherapy of Trypanosoma cruzi infection: persistence of parasite antigens and positive serology in parasitologically cured mice. Andrade SG; Freitas LA; Peyrol S; Pimentel AR; Sadigursky M Bull World Health Organ; 1991; 69(2):191-7. PubMed ID: 1907221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]